Maria Issagouliantis

Maria Issagouliantis serves as both Associate Professor of Immunology at Karolinska Institutet (since 2007) and Coordinator of Joint Operational Support (since 2024). Her dual roles bridge academic research with administrative leadership in research support services at one of Europe's premier medical universities.

Dr. Issagouliantis's research focuses on the complex interplay between viral infections and cancer development, with particular expertise in HIV and HPV virology. Her work examines how viral proteins like reverse transcriptase and protease influence tumor progression through mechanisms including oxidative stress, metabolic reprogramming, and epithelial-mesenchymal transition. She has made significant contributions to DNA vaccine development, particularly for targeting drug-resistant viral variants.

Analysis of her recent publications (2020-2024) reveals a consistent focus on viral carcinogenesis mechanisms, with increasing attention to translational applications of immunization strategies. Her work spans basic molecular mechanisms to clinical epidemiology, with notable studies on HPV-HIV co-infections in cancer development and the application of novel vaccine platforms including mRNA technologies.

Dr. Issagouliantis maintains active research collaborations across international boundaries, with co-authorship on studies involving institutions in Europe, Russia, and the United States. Her leadership in the Grants Office suggests strong involvement in research administration and funding acquisition, though specific grant details aren't provided in the available information.

Her laboratory work, while not formally named in the available information, appears to focus on viral immunology and carcinogenesis, utilizing both in vitro and in vivo models to study viral protein effects on cellular processes and immune responses. The extensive publication record demonstrates a productive research environment with consistent output across multiple virology and immunology journals.